Synthesis, characterization, in silico anti-ovarian cancer activity and quantum chemical calculations of 3-β-(2-(6-methoxynaphthalene-2yl)propionoxy)-stigmast-5-en
Abstract
The current research work incorporates the synthesis, spectroscopic analysis, in silico studies to evaluate anti-ovarian cancer potential and theoretical studies of 3-β-(2-(6 methoxynaphthalene-2yl)propionoxy)-stigmast-5-en (2). Synthesis of compound 2 was carried out by conjugating β-sitosterol (1) with Naproxen through highly efficient Steglich esterification. The structure elucidation of the synthesised compound was done using 1H NMR, IR and UV as well as mass spectrometry. Anti-ovarian cancer potential of the compound 2 was evaluated using its interaction with the ovarian cancer protein 2UZR (binding energy (ΔG) of -6.0 Kcal/mole) with the help of molecular docking studies. Topological parameters were analyzed by "Atom in molecule" AIM theory. High value of first hyper polarizability, (βo = , of compound 2 indicates that it can be utilised as ideal material for NLO applications.
How strong is the evidence?
Evidence Hub reads this as a simulation / modelling, done in computer models (in silico), not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Chaos and quantum thermalization
- The Dalton quantum chemistry program system
- Cord Blood Leptin and Adiponectin as Predictors of Adiposity in Children at 3 Years of Age: A Prospective Cohort Study
- Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes
- Stable adiabatic quantum batteries
- A novel self-lipid antigen targets human T cells against CD1c(+) leukemias
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.